Advanced Search
Contact | Corporate | Help

RAD001 Plus Bevacizumab in Metastatic Melanoma

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
  • Novartis
Phases:
  • Phase II
IndicationsAcronym:
  • Metastatic Melanoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: RAD001, Bevacizumab
Enrollment:
55

Additional information about NCT00591734.


SourceSolution © 2008-2012